This week in charts: a big year for RNAi developers
The latest installment in BioPharma Dive’s data visualization series features a look at the emerging popularity of RNAi developers, and the funding that came with it.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.